Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Breast Neoplasms 54Lung Neoplasms 29Colorectal Neoplasms 24Prostatic Neoplasms 23Colonic Neoplasms 16Rectal Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Neoplasms 13Uterine Cervical Neoplasms 12Lymphoma 11Urinary Bladder Neoplasms 8Leukemia 8Endometrial Neoplasms 8Depression 8Pancreatic Neoplasms 7Ovarian Neoplasms 7Leukemia, Myeloid, Acute 7Breast Carcinoma In Situ 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Pain 6Multiple Myeloma 6Melanoma 6Hematologic Neoplasms 6Carcinoma, Ovarian Epithelial 6Anxiety Disorders 6Obesity 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hematopoietic and Lymphatic System Neoplasm 5Fatigue 5Burkitt Lymphoma 5

Interventions

Standard of Care 1Spinal Cord Stimulation 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chemotherapy-Induced Peripheral Neuropathy × Early Intervention, Educational × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡